![Michael Chiu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Chiu
Vorstandsvorsitzender bei Kytopen Corp.
Profil
Michael Chiu is currently the Chief Executive Officer at Kytopen Corp.
Previously, he held the position of President, Chief Executive Officer & Director at Erbi Biosystems, Inc. He completed his undergraduate degree at the University of Minnesota and his graduate and doctorate degrees at the Massachusetts Institute of Technology AgeLab.
Aktive Positionen von Michael Chiu
Unternehmen | Position | Beginn |
---|---|---|
Kytopen Corp.
![]() Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 07.08.2023 |
Ehemalige bekannte Positionen von Michael Chiu
Unternehmen | Position | Ende |
---|---|---|
Erbi Biosystems, Inc.
![]() Erbi Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Erbi Biosystems, Inc. builds systems to automate the study of microorganisms for basic research. The company is headquartered In Woburn, MA. | Vorstandsvorsitzender | - |
Ausbildung von Michael Chiu
University of Minnesota | Undergraduate Degree |
Massachusetts Institute of Technology AgeLab | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Erbi Biosystems, Inc.
![]() Erbi Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Erbi Biosystems, Inc. builds systems to automate the study of microorganisms for basic research. The company is headquartered In Woburn, MA. | Health Technology |
Kytopen Corp.
![]() Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Commercial Services |